2014 Q1 Form 10-Q Financial Statement

#000114420414008385 Filed on February 13, 2014

View on sec.gov

Income Statement

Concept 2014 Q1 2013 Q4 2012 Q4
Revenue $2.637M $3.739M $4.754M
YoY Change -35.9% -21.35% 49.02%
Cost Of Revenue $2.480M $2.610M $3.730M
YoY Change -15.93% -30.03% 57.38%
Gross Profit $157.0K $1.125M $1.027M
YoY Change -86.49% 9.58% 25.25%
Gross Profit Margin 5.96% 30.1% 21.61%
Selling, General & Admin $1.050M $1.077M $1.291M
YoY Change -6.25% -16.55% 24.1%
% of Gross Profit 668.64% 95.7% 125.66%
Research & Development $220.0K $146.4K $124.1K
YoY Change 29.41% 17.99% -11.38%
% of Gross Profit 140.1% 13.01% 12.08%
Depreciation & Amortization $10.00K $10.00K $10.00K
YoY Change 0.0% 0.0% 0.0%
% of Gross Profit 6.37% 0.89% 0.97%
Operating Expenses $1.280M $1.223M $1.415M
YoY Change -0.78% -13.52% 20.92%
Operating Profit -$1.123M -$97.99K -$387.7K
YoY Change 781.88% -74.72% 10.76%
Interest Expense -$380.0K -$270.0K $590.0K
YoY Change -246.15% -145.76% 90.32%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$1.500M -$367.2K $206.9K
YoY Change -1171.43% -277.48% -513.79%
Income Tax $0.00 $0.00 $183.6K
% Of Pretax Income 88.76%
Net Earnings -$1.504M -$367.2K $23.26K
YoY Change -1533.04% -1678.84% -66.78%
Net Earnings / Revenue -57.05% -9.82% 0.49%
Basic Earnings Per Share -$0.65 -$0.16 $0.01
Diluted Earnings Per Share -$0.65 -$0.16 $0.01
COMMON SHARES
Basic Shares Outstanding 2.288M shares 2.288M shares 2.311M shares
Diluted Shares Outstanding 2.288M shares 2.314M shares

Balance Sheet

Concept 2014 Q1 2013 Q4 2012 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.050M $1.920M $2.540M
YoY Change -15.98% -24.41% -46.3%
Cash & Equivalents $2.051M $1.918M $2.544M
Short-Term Investments
Other Short-Term Assets $410.0K $260.0K $430.0K
YoY Change -31.67% -39.53% -10.42%
Inventory $4.194M $4.751M $4.900M
Prepaid Expenses $406.0K $258.7K
Receivables $686.2K $621.6K $850.0K
Other Receivables $1.470M $2.060M $1.610M
Total Short-Term Assets $8.940M $9.660M $10.34M
YoY Change -13.19% -6.58% -16.21%
LONG-TERM ASSETS
Property, Plant & Equipment $146.2K $125.1K $150.0K
YoY Change -3.93% -16.6% -16.67%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $14.00M $14.54M $13.48M
YoY Change -6.07% 7.88% 1.66%
Other Assets $38.13K $38.13K $2.390M
YoY Change 0.0% -98.4% 9.13%
Total Long-Term Assets $14.26M $14.78M $16.10M
YoY Change -18.44% -8.18% 2.48%
TOTAL ASSETS
Total Short-Term Assets $8.940M $9.660M $10.34M
Total Long-Term Assets $14.26M $14.78M $16.10M
Total Assets $23.20M $24.44M $26.44M
YoY Change -16.5% -7.56% -5.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $606.3K $298.9K $670.0K
YoY Change 10.56% -55.4% -45.08%
Accrued Expenses $150.0K $150.0K $160.0K
YoY Change -16.67% -6.25% 6.67%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $785.6K $451.0K $830.0K
YoY Change 7.91% -45.66% -39.86%
LONG-TERM LIABILITIES
Long-Term Debt $25.00K $25.00K $30.00K
YoY Change 0.0% -16.67%
Other Long-Term Liabilities $0.00
YoY Change
Total Long-Term Liabilities $25.00K $25.00K $30.00K
YoY Change 0.0% -16.67% 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $785.6K $451.0K $830.0K
Total Long-Term Liabilities $25.00K $25.00K $30.00K
Total Liabilities $810.6K $476.0K $860.0K
YoY Change 7.65% -44.65% -38.57%
SHAREHOLDERS EQUITY
Retained Earnings $8.293M $9.939M
YoY Change -35.64%
Common Stock $12.91M $12.83M
YoY Change 1.07%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $22.39M $23.97M $25.58M
YoY Change
Total Liabilities & Shareholders Equity $23.20M $24.44M $26.44M
YoY Change -16.5% -7.56% -5.74%

Cashflow Statement

Concept 2014 Q1 2013 Q4 2012 Q4
OPERATING ACTIVITIES
Net Income -$1.504M -$367.2K $23.26K
YoY Change -1533.04% -1678.84% -66.78%
Depreciation, Depletion And Amortization $10.00K $10.00K $10.00K
YoY Change 0.0% 0.0% 0.0%
Cash From Operating Activities $150.0K $680.0K $1.310M
YoY Change -157.69% -48.09% 991.67%
INVESTING ACTIVITIES
Capital Expenditures -$30.00K $0.00 $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$60.00K $220.0K $0.00
YoY Change -127.27% -100.0%
Cash From Investing Activities -$100.0K $220.0K $10.00K
YoY Change -150.0% 2100.0% -50.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 80.00K 0.000 -50.00K
YoY Change -233.33% -100.0% -54.55%
NET CHANGE
Cash From Operating Activities 150.0K 680.0K 1.310M
Cash From Investing Activities -100.0K 220.0K 10.00K
Cash From Financing Activities 80.00K 0.000 -50.00K
Net Change In Cash 130.0K 900.0K 1.270M
YoY Change -208.33% -29.13% 4133.33%
FREE CASH FLOW
Cash From Operating Activities $150.0K $680.0K $1.310M
Capital Expenditures -$30.00K $0.00 $0.00
Free Cash Flow $180.0K $680.0K $1.310M
YoY Change -169.23% -48.09% 991.67%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
235122 USD
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
38134 USD
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2438892 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1917866 USD
CY2013Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
153175 USD
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
621554 USD
CY2013Q1 us-gaap Other Receivables
OtherReceivables
65375 USD
CY2013Q4 us-gaap Other Receivables
OtherReceivables
67698 USD
CY2013Q1 us-gaap Due From Joint Ventures Current
DueFromJointVenturesCurrent
419219 USD
CY2013Q4 us-gaap Due From Joint Ventures Current
DueFromJointVenturesCurrent
49763 USD
CY2013Q1 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
637769 USD
CY2013Q4 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
739015 USD
CY2013Q1 uuu Due From Factor
DueFromFactor
2281662 USD
CY2013Q4 uuu Due From Factor
DueFromFactor
1992680 USD
CY2013Q1 us-gaap Inventory Net
InventoryNet
4341652 USD
CY2013Q4 us-gaap Inventory Net
InventoryNet
4751345 USD
CY2013Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
598686 USD
CY2013Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
258660 USD
CY2013Q1 us-gaap Assets Current
AssetsCurrent
10298661 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
9659566 USD
CY2013Q1 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
2310835 USD
CY2013Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
0 USD
CY2013Q1 us-gaap Liabilities Current
LiabilitiesCurrent
727990 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
451044 USD
CY2013Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
25000 USD
CY2013Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
25000 USD
CY2013Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q1 us-gaap Common Stock Value
CommonStockValue
22879 USD
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
22879 USD
CY2013Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
12749256 USD
CY2013Q1 us-gaap Equity Method Investments
EquityMethodInvestments
14906573 USD
CY2013Q4 us-gaap Equity Method Investments
EquityMethodInvestments
14542448 USD
CY2013Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
152201 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
125097 USD
CY2013Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
80491 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
77137 USD
CY2013Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
38134 USD
CY2013Q1 us-gaap Assets
Assets
27786895 USD
CY2013Q4 us-gaap Assets
Assets
24442382 USD
CY2013Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
548388 USD
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
298853 USD
CY2013Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
103890 USD
CY2013Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
106533 USD
CY2013Q1 uuu Commissions And Other
CommissionsAndOther
75712 USD
CY2013Q4 uuu Commissions And Other
CommissionsAndOther
45658 USD
CY2013Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
12804841 USD
CY2013Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
12885360 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
9939421 USD
CY2013Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1376410 USD
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1199197 USD
CY2013Q1 us-gaap Stockholders Equity
StockholdersEquity
27033905 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
23966338 USD
CY2013Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
27786895 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
24442382 USD
us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
16951783 USD
us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
16424133 USD
us-gaap Equity Method Investment Summarized Financial Information Gross Profit Loss
EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss
4275838 USD
us-gaap Equity Method Investment Summarized Financial Information Gross Profit Loss
EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss
4283152 USD
us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
1046690 USD
us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
633945 USD
CY2012Q4 us-gaap Equity Method Investment Summarized Financial Information Current Assets
EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets
13643152 USD
CY2013Q4 us-gaap Equity Method Investment Summarized Financial Information Current Assets
EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets
15148093 USD
CY2012Q4 us-gaap Equity Method Investment Summarized Financial Information Assets
EquityMethodInvestmentSummarizedFinancialInformationAssets
34622174 USD
CY2013Q4 us-gaap Equity Method Investment Summarized Financial Information Assets
EquityMethodInvestmentSummarizedFinancialInformationAssets
35368407 USD
CY2012Q4 us-gaap Equity Method Investment Summarized Financial Information Current Liabilities
EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities
4764335 USD
CY2013Q4 us-gaap Equity Method Investment Summarized Financial Information Current Liabilities
EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities
6005538 USD
CY2013Q4 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
0.5 pure
uuu Products Purchased From Joint Venture
ProductsPurchasedFromJointVenture
6899560 USD
uuu Products Purchased From Joint Venture
ProductsPurchasedFromJointVenture
6122297 USD
uuu Increase Or Decrease In Inter Company Profit In Inventory
IncreaseOrDecreaseInInterCompanyProfitInInventory
60829 USD
uuu Increase Or Decrease In Inter Company Profit In Inventory
IncreaseOrDecreaseInInterCompanyProfitInInventory
154536 USD
CY2013Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
300000 USD
CY2012Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
57000 USD
CY2013Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
57000 USD
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2317315 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2287887 shares
CY2012Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2310672 shares
CY2013Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2287887 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2012Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
3666 shares
CY2013Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2317315 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2287887 shares
CY2012Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2314338 shares
CY2013Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2287887 shares
CY2009Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
25000 shares
CY2009Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.25
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
55585 USD
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
27000 USD
us-gaap Other Comprehensive Income Other Net Of Tax
OtherComprehensiveIncomeOtherNetOfTax
-177213 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
11269901 USD
CY2013 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
158942 USD
CY2012Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
42323 USD
uuu Increase Decrease In Other Comprehensive Income Loss
IncreaseDecreaseInOtherComprehensiveIncomeLoss
304250 USD
CY2013 uuu Increase Decrease In Other Comprehensive Income Loss
IncreaseDecreaseInOtherComprehensiveIncomeLoss
452561 USD
CY2012Q4 uuu Increase Decrease In Other Comprehensive Income Loss
IncreaseDecreaseInOtherComprehensiveIncomeLoss
65580 USD
CY2013Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
57000 USD
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000 shares
CY2013Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2287887 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2287887 shares
CY2013Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2287887 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2287887 shares
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
9940194 USD
CY2012Q4 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
4753736 USD
CY2013Q4 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
3738914 USD
uuu Cost Of Goods Sold Acquired From Joint Venture
CostOfGoodsSoldAcquiredFromJointVenture
7679691 USD
uuu Cost Of Goods Sold Acquired From Joint Venture
CostOfGoodsSoldAcquiredFromJointVenture
6735324 USD
CY2013Q4 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-21250 USD
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
91930 USD
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-140633 USD
CY2012Q4 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-28981 USD
CY2012Q4 uuu Cost Of Goods Sold Acquired From Joint Venture
CostOfGoodsSoldAcquiredFromJointVenture
3585736 USD
CY2013Q4 uuu Cost Of Goods Sold Acquired From Joint Venture
CostOfGoodsSoldAcquiredFromJointVenture
2603231 USD
uuu Cost Of Goods Sold Other
CostOfGoodsSoldOther
411473 USD
uuu Cost Of Goods Sold Other
CostOfGoodsSoldOther
520921 USD
CY2012Q4 uuu Cost Of Goods Sold Other
CostOfGoodsSoldOther
140940 USD
CY2013Q4 uuu Cost Of Goods Sold Other
CostOfGoodsSoldOther
10213 USD
us-gaap Gross Profit
GrossProfit
3178737 USD
us-gaap Gross Profit
GrossProfit
2683949 USD
CY2012Q4 us-gaap Gross Profit
GrossProfit
1027060 USD
CY2013Q4 us-gaap Gross Profit
GrossProfit
1125470 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
373758 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
367529 USD
CY2012Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
124063 USD
CY2013Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
146385 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3893485 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3198561 USD
CY2012Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1290650 USD
CY2013Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1077071 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-1088506 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-882141 USD
CY2012Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-387653 USD
CY2013Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-97986 USD
us-gaap Interest And Other Income
InterestAndOtherIncome
19972 USD
us-gaap Interest And Other Income
InterestAndOtherIncome
17674 USD
CY2012Q4 us-gaap Interest And Other Income
InterestAndOtherIncome
5120 USD
CY2013Q4 us-gaap Interest And Other Income
InterestAndOtherIncome
5852 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1004310 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-864467 USD
CY2012Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-382533 USD
CY2013Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-92134 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
462515 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
229363 USD
CY2012Q4 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
589426 USD
CY2013Q4 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-275057 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-541795 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-635104 USD
CY2012Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
206893 USD
CY2013Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-367191 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15739 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2310835 USD
CY2012Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
183636 USD
CY2013Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Net Income Loss
NetIncomeLoss
-557534 USD
us-gaap Net Income Loss
NetIncomeLoss
-2945939 USD
CY2012Q4 us-gaap Net Income Loss
NetIncomeLoss
23257 USD
CY2013Q4 us-gaap Net Income Loss
NetIncomeLoss
-367191 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.24
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.29
CY2012Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2013Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.16
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.24
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.29
CY2012Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2013Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.16
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-36580 USD
CY2013Q4 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-12891 USD
CY2012Q4 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-36599 USD
CY2013Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-401332 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-253284 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3123152 USD
CY2012Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-42323 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-47853 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-2310835 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
33658 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
30458 USD
us-gaap Share Based Compensation
ShareBasedCompensation
66700 USD
us-gaap Share Based Compensation
ShareBasedCompensation
55585 USD
uuu Increase Decrease In Accounts Receivable And Due From Factor
IncreaseDecreaseInAccountsReceivableAndDueFromFactor
-140110 USD
uuu Increase Decrease In Accounts Receivable And Due From Factor
IncreaseDecreaseInAccountsReceivableAndDueFromFactor
-128081 USD
uuu Increase Decrease In Inventories And Prepaid Expenses
IncreaseDecreaseInInventoriesAndPrepaidExpenses
-666765 USD
uuu Increase Decrease In Inventories And Prepaid Expenses
IncreaseDecreaseInInventoriesAndPrepaidExpenses
69667 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-462101 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-276946 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-527064 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-996956 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8704 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 USD
uuu Proceeds From Dividend Distributions From Joint Venture
ProceedsFromDividendDistributionsFromJointVenture
64974 USD
uuu Proceeds From Dividend Distributions From Joint Venture
ProceedsFromDividendDistributionsFromJointVenture
475930 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
56270 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
475930 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
171469 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-171469 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-642263 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-521026 USD
CY2012Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3186274 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2544011 USD
us-gaap Interest Paid
InterestPaid
0 USD
us-gaap Interest Paid
InterestPaid
0 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
dei Document Type
DocumentType
10-Q
dei Amendment Flag
AmendmentFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2013-12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Trading Symbol
TradingSymbol
UUU
CY2014Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
2287887 shares
dei Entity Registrant Name
EntityRegistrantName
UNIVERSAL SECURITY INSTRUMENTS INC
dei Entity Central Index Key
EntityCentralIndexKey
0000102109
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
64224 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 USD
CY2012Q4 uuu Products Sales From Joint Venture
ProductsSalesFromJointVenture
6380366 USD
CY2013Q4 uuu Products Sales From Joint Venture
ProductsSalesFromJointVenture
3661251 USD
CY2012Q4 uuu Net Income Loss From Joint Venture
NetIncomeLossFromJointVenture
849969 USD
CY2013Q4 uuu Net Income Loss From Joint Venture
NetIncomeLossFromJointVenture
531125 USD

Files In Submission

Name View Source Status
0001144204-14-008385-index-headers.html Edgar Link pending
0001144204-14-008385-index.html Edgar Link pending
0001144204-14-008385.txt Edgar Link pending
0001144204-14-008385-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tlogo.jpg Edgar Link pending
uuu-20131231.xml Edgar Link completed
uuu-20131231.xsd Edgar Link pending
uuu-20131231_cal.xml Edgar Link unprocessable
uuu-20131231_def.xml Edgar Link unprocessable
uuu-20131231_lab.xml Edgar Link unprocessable
uuu-20131231_pre.xml Edgar Link unprocessable
v366462_10q.htm Edgar Link pending
v366462_ex31-1.htm Edgar Link pending
v366462_ex31-2.htm Edgar Link pending
v366462_ex32-1.htm Edgar Link pending
v366462_ex99-1.htm Edgar Link pending